The reality of hospital value analysis committees means product adoption takes years. Entrepreneurs must build this lengthy timeline into financial models and fundraising to ensure survival, rather than projecting rapid uptake.
The SmallTap cradle was conceived when a frustrated hospitalist, after a difficult procedure, had a chance encounter with a neonatologist who was also a former architect and teaching a device design class. This fusion of acute clinical need with outside expertise sparked the innovation.
For SmallTap, niche medical conferences yield the highest ROI, with the CEO stating that 'almost all' of their sales originate from in-person booth conversations. This positions conferences as a core sales-closing channel, far more critical than simple lead generation.
While SmallTap's higher clinical success rate is key, its adoption is driven by benefits to multiple stakeholders. The messaging highlights reduced physical strain on nurses, lower stress for doctors, and a clear financial ROI for hospitals by avoiding unnecessary admittances.
Instead of raising large sums to hire a direct sales force, SmallTap partnered with regional specialty distributors. This strategy minimized equity dilution and leveraged existing sales relationships for broad market access without the high fixed costs of full-time employees.
SmallTap's CEO consciously avoided trying to master every domain, instead leaning on external experts for regulatory, legal, and marketing. He frames this as "renting people's brains," a strategy he credits with saving hundreds of thousands of dollars compared to hiring or trial-and-error.